The ÆGIS Microbe Shield has been used widely in hospital applications for a great number of years to great effect in controlling against a broad spectrum of all known bacteria, fungi, and algae.
Healthcare facilities, by the very nature of their operation, expose patients and staff to microbial contamination that can lead to infectious disease. Healthcare associated infections (HAI) are among the top ten causes of death in the United States. HAI is estimated to result in as many as 98,000 deaths each year at an annual cost of up to $29 billion.
Flooring, doorknobs, curtains, cabinets and the "forgotten" surfaces, such as walls, can potentially transfer contaminating organisms from surface to surface and person to person. Healthcare associated infections occur to approximately one in ten patients, resulting in higher treatment costs and increased potential for litigation.
Treatment of frequently touched surfaces in hospitals and health care facilities will be valuable in assisting with control of all other infectious microbes found or of concern in these environments. Some of these include Escherischia coli, influenza virus, Salmonella and Bacillus anthracis.
Additional benefits of the ÆGIS Microbe Shield antimicrobial technology include controlling odour, staining and deterioration caused by mould, mildew and other microbial organisms, thereby creating a more pleasant environment. This technology stays where it is put and has its mode of action is physical, not chemical.
The Role of the AEGIS Microbe Shield in Infection Control
The spread of infectious microbes is a worldwide and ongoing phenomenon.
Antimicrobial tools that will be effective to reduce transmission of infectious microbes must be able to accomplish all of the following:
The AEGIS Microbe Shield, used throughout the world on all indoor environmental surfaces and on clean room garments, touch screens, hospital supplies and many other consumer goods has these characteristics.
The AEGIS Microbe Shield does NOT promote genetic adaptation
The mode of action of the AEGIS Microbe Shield does not promote any genetic adaptation or selection process. This is the single greatest negative impact to the use of ANY product to kill germs – some of them will simply survive and, if that trait is heritable, will be selectively passed on to subsequent generations.